MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  
rheumatology image

Rheumatology Drugs

Prescription drugs and medicines for conditions relating to joints, tendons, muscles, ligaments, and associated structures. Studies in this area include: arthritis, osteoarthritis, psoriasis, rheumatic fever, rheumatoid arthritis, and others.

The list of FDA approved drugs for rheumatology appears below. Click any link to view the full drug information.


Bookmark and Share
Number Of Rheumatology Drugs: 42

Actemra (ocilizumab)
For the treatment of Polyarticular Juvenile Idiopathic Arthritis
Actemra (tocilizumab)
For the treatment of systemic juvenile idiopathic arthritis
Actemra (tocilizumab)
For the treatment of rheumatoid arthritis
Arava
Treatment for Rheumatoid Arthritis
Arthrotec
Treatment for arthritis
Bextra
Oral tablet for the treatment of osteoarthritis, rheumatoid arthritis and menstrual pain
Cimzia (certolizumab pegol)
For the treatment of rheumatoid arthritis
Colcrys (colchicine)
For gout flares and familial Mediterranean fever
Duexis (ibuprofen and famotidine)
For the relief of rheumatoid arthritis and osteoarthritis and prevention of gastric ulcers
Elaprase (idursulfase)
For the treatmenr of mucopolysaccharidosis II (Hunter Syndrome)
Enbrel (etanercept)
For the treatment of psoriatic arthritis
Etodolac
Generic equivalent of Lodine
Etodolac
Generic equivalent of Lodine
Humira (adalimumab)
For the treatment of moderately to severely active rheumatoid arthritis
Ilaris (canakinumab)
For the treatment of Systemic Juvenile Idiopathic Arthritis
Ketoprofen
Generic equivalent or Oruvail
Kineret
Injectable therapy for the treatment of rheumatoid arthritis
Krystexxa (pegloticase)
For the treatment of chronic gout (hyperuricemia)
Lodine (etodolac)
Treatment for rheumatoid arthritis
Lodine XL (etodolac)
Treatment for arthritis
Lodine XL (etodolac)
Treatment for the signs and symptoms of osteoarthritis and rheumatoid arthritis
Mobic (meloxicam) Tablets
For relief of the signs and symptoms of osteoarthritis
Naprelan (naproxen sodium)
Treatment for osteoarthritis and rheumatoid arthritis
Orencia (abatacept)
For the Treatment of Rheumatoid Arthritis
Orencia (abatacept)
For the treatment of Juvenile Idiopathic Arthritis
Otezla (apremilast)
For the treatment of adults with active psoriatic arthritis
Pennsaid (diclofenac sodium topical solution)
For the treatment of osteoarthritis of the knee
Rayos (prednisone) delayed-release tablets
For the treatment of certain inflammatory diseases, including arthritis, COPD, asthma and psoriatic conditions
Remicade (infliximab)
For inhibiting the progression of structural damage in patients with rheumatoid arthritis
Remicade (infliximab)
Intravenous infusion for the treatment of rheumatoid arthritis
Salagen Tablets
Treatment for Sjogren's Syndrome
Simponi (golimumab)
For the treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Stendra (avanafil)
For the treatment of erectile dysfunction
Supartz
Joint fluid therapy for treatment of osteoarthritis in the knee
Synvisc, Synvisc-One (Hylan GF 20)
For the treatment of pain associated with osteoarthritis of the knee
Tolmetin Sodium
Treatment for arthritis
Uloric (febuxostat)
For the treatment of chronic hyperuricemia in patients with gout
Vimovo (naproxen + esomeprazole)
For the treatment of arthritis in patients at risk for NSAID-associated ulcers
Vioxx (rofecoxib)
For the treatment of rheumatoid arthritis
Vivelle (estradiol transdermal system)
For the prevention of postmenopausal osteoporosis
Xeljanz (tofacitinib)
For the treatment of moderately to severely active rheumatoid arthritis


« back to top
FDA Approved Rheumatology Drugs Listings:

The rules of principle for evaluating MediLexicon's FDA rheumatology drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.

MediLexicon's FDA Approved Drugs Listings include:

New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.

MediLexicon's FDA Approved Drugs Listings do NOT include:

Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.

The rheumatology drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.









MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.